Imatinib Completed Phase 2 Trials for Male Breast Cancer / Recurrent Breast Cancer / Stage IV Breast Cancer Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00045188Imatinib Mesylate in Treating Patients With Metastatic Breast Cancer